Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: interim results from GARNET-a phase I, single-arm study.

Ana OakninLucy GilbertAnna V TinkerJubilee BrownCara MathewsJoshua PressRenaud SabatierDavid M O'MalleyVanessa SamouelianValentina BoniLinda DuskaSharad GhamandePrafull GhatageRebecca KristeleitCharles III LeathWei GuoEllie ImSybil ZildjianXinwei HanTao DuanJennifer VenerisBhavana Pothuri

Published in: Journal for immunotherapy of cancer (2022)

NCT02715284.

Keyphrases

endometrial cancer
circulating tumor
single molecule
cell free
nucleic acid